Navigation Links
Pediatricians and Psychiatrists Debate Wider Diagnosing, Prescribing Guidelines for ADHD
Date:10/21/2011

NORWALK, Conn., Oct. 21, 2011 /PRNewswire-iReach/ -- Physicians on UBM Medica's physician-led web sites are protesting and debating new guidelines just released for the diagnosis and treatment of ADHD. The guidelines, "ADHD: Clinical Practice Guidelines for the Diagnosis, Evaluation and Treatment of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder," were released earlier this week by the American Academy of Pediatrics (AAP). They call for children as young as 4 years old to be diagnosed and treated with medications for ADHD.

(Photo:  http://photos.prnewswire.com/prnh/20111021/CG90660)

But psychiatrists and pediatricians on Pediatrics Consultant Live (www.PediatricsConsultantLive.com) and Psychiatric Times (www.PsychiatricTimes.com) are debating whether that is sound advice.

Dr. Allen Frances, chair of the DSM-IV Task Force and of the department of psychiatry at Duke University School of Medicine, Durham, N.C., calls the guidelines "reckless."

"This radical suggestion will further the already problematic overdiagnosis of ADD and expand the inappropriate prescription of medication to young children," he comments. "It is absolutely clear that medication can be very helpful for ADD in carefully diagnosed school-age kids who have moderate/severe problems and who have not responded to patient watchful waiting, parent training, and behavioral interventions. But in busy practice settings, ADD is often inaccurately diagnosed and prematurely treated with medication. This should be a treatment of very last resort in preschoolers, reserved for those with the most severe problems and delivered by those with the greatest expertise."

While these guidelines are undoubtedly well-intended, the fear is how they'll be implemented in busy, real-world practices.

A poll on Pediatrics Consultant Live is gathering pediatricians' opinions about the change.

"It's not at all unusual for clinical authorities to issue guidelines that trouble practicing physicians," said UBM Medica SVP of Content and Strategy, Pamela Moore. "We've seen it just this month with changes to prostate screening guidelines and now ADHD. Sites like Psychiatric Times and Pediatrics Consultant Live allow the debates to happen, allow the rifts in medicine to be revealed, so that physicians and patients get the real story. Medicine is complex. Better outcomes are hard. There's no sense in papering over real debates in medicine."

About UBM Medica

Addressing today's healthcare information needs, UBM Medica, a division of UBM plc (UBM.L), delivers strategic, integrated communications solutions and comprehensive reach—online, in print, live, and via custom programs. Improving the effectiveness of healthcare through information and education, UBM Medica provides unbiased clinical, practical, and business information for physicians, providers, payers, and patients around the world. Through journals, magazines, websites, drug databases, data services, live events, and other valuable resources, UBM Medica also delivers comprehensive communication solutions for the pharmaceutical and related industries. US websites include PsychiatricTimes.com, CancerNetwork.com, DiagnosticImaging.com, ConsultantLive.com, OBGYN.net, PhysiciansPractice.com and SearchMedica.com.  Employing more than 1,400 people with offices in 29 countries, UBM Medica is headquartered in London. For more information, visit http://www.ubmmedica.com/.

Media Contact: Amy Erdman UBM Medica, 203-523-7041, amy.erdman@ubm.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE UBM Medica
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. UPDATE: New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
2. New Report by Pediatricians Finds Gaps in Preparing to Protect Kids From Pandemic Flu, Offers Recommendations
3. ImpactRx Expands Psychiatry Research Panel to Include Adolescent Psychiatrists
4. Results of the Phase III Pivotal Study of VYVANSE(TM) (Lisdexamfetamine Dimesylate) for the Treatment of ADHD in Adults Presented at National Scientific Meeting of Psychiatrists
5. A Sociolinguistic Analysis of In-Office Dialogue Reveals Psychiatrists and Parents Have Significantly Different Perceptions on ADHD and Psychiatric Comorbidities
6. Online Forum for Accountable Care Organization Developments Launches Today; Squire Sanders Sponsorship Reflects Commitment to Leadership in Emerging Health Policy Debate
7. Mississippians React to Rushed Pseudoephedrine Debate Raging in the State Legislature
8. AST Concerned That Kidney Transplant Patients May Suffer Politics As Usual in Capitol Hill Health Care Reform Debate
9. Time to Blow Up the Pharmaceutical Sales Model? New Deloitte Debate
10. Medical Technology Executives Descend on D.C. as AdvaMed 2009: The MedTech Conference Kicks Off and Health Care Debate Continues
11. Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... -- One of Australia,s successful biotechnology scientists, ... new biotechnology company, Noxopharm Limited [ABN 50 608 966 123] ("Noxopharm"). ... list on the ASX. Noxopharm is a clinic-ready company ... Phase 1 clinical study later this year. ... biggest problems facing cancer patients - the ability of cancers to ...
(Date:6/26/2016)... 2016 Jazz Pharmaceuticals plc (Nasdaq: ... Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended ("HSR"), ... Inc. ("Celator"; Nasdaq: CPXX ) expired effective ... As previously announced on May 31, 2016, ... agreement under which Jazz Pharmaceuticals has commenced a tender ...
(Date:6/26/2016)... Ontario , June 27, 2016  VMS Rehab ... Company,s Board will take whatever measures required to build ... Company,s stock which is currently listed on the OTC ... Wexler, Company Chairman and CEO, "We are seeing an ... difficult to understand, not only by the Company, but ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... ... and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the Hynes ... important health care topics including advance care planning, healthcare costs and patient and ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set of ... or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, Serenity ... event. , Trauma sufferers tend to feel a range of emotions, from depression, guilt, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
(Date:6/24/2016)... ... 24, 2016 , ... The Haute Beauty Network, affiliated with ... as a prominent plastic surgeon and the network’s newest partner. , Dr. ... handsome men, look naturally attractive. Plastic surgery should be invisible.” He stands by ...
Breaking Medicine News(10 mins):